The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.
 
Ryan Austin Denu
No Relationships to Disclose
 
Rossana Lazcano Segura
No Relationships to Disclose
 
Ahsan Saleem Farooqi
No Relationships to Disclose
 
Davis Ingram
No Relationships to Disclose
 
Khalida M. Wani
No Relationships to Disclose
 
Yiming Cai
No Relationships to Disclose
 
Keila E Torres
No Relationships to Disclose
 
Emily Zhi-Yun Keung
No Relationships to Disclose
 
Christina Lynn Roland
Consulting or Advisory Role - Lumanity
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - AADi; Bayer; Blueprint Medicines; Boehringer Ingelheim; Deciphera; Epizyme
Research Funding - Advenc; Ascentage Pharma; AstraZeneca/MedImmune (Inst); Cogent Biosciences; Daiichi Sankyo/Lilly; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics
 
Haoqiang Ying
No Relationships to Disclose
 
Jason T. Huse
Research Funding - Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Taiho Pharmaceutical; Taiho Pharmaceutical
 
Kunal Rai
No Relationships to Disclose
 
Anthony Paul Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Rain Oncology
Research Funding - PTC Therapeutics; Rain Therapeutics (Inst)
 
Wei-Lien Wang
No Relationships to Disclose
 
Alexander J. Lazar
Leadership - Archer; Iterion Therapeutics; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals; PAIGE.AI
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; BMS; Deciphera; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Elise F Nassif Haddad
Honoraria - Sonata Therapeutics